
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease ... Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1836 | -61.7142857143 | 0.2975 | 0.315764 | 0.1139 | 7100682 | 0.13446561 | CS |
4 | -0.2071 | -64.5171339564 | 0.321 | 0.347 | 0.1139 | 2009607 | 0.15266014 | CS |
12 | -0.2652 | -69.9551569507 | 0.3791 | 0.446 | 0.1139 | 897854 | 0.20640852 | CS |
26 | -0.4118 | -78.3336503709 | 0.5257 | 0.608 | 0.1139 | 726509 | 0.31420061 | CS |
52 | -0.5791 | -83.5642135642 | 0.693 | 0.87 | 0.1139 | 591073 | 0.41777666 | CS |
156 | -2.0161 | -94.6525821596 | 2.13 | 5.95 | 0.1139 | 489228 | 1.39084822 | CS |
260 | -16.8861 | -99.33 | 17 | 35.6 | 0.1139 | 565419 | 3.00021388 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約